Retrospective analysis of nanoparticle albumin-encapsulated paclitaxel versus dacarbazine in advanced melanoma

被引：0
|
作者：
Chalasani, P. [1 ]
Morgan, S. S. [1 ]
Butcher, D. [1 ]
Jeter, J. M. [1 ]
Hersh, E. [1 ]
Cranmer, L. D. [1 ]
机构：
[1] Univ Arizona, Arizona Canc Ctr, Tucson, AZ USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2010年 / 28卷 / 15期
关键词：
D O I：
10.1200/jco.2010.28.15_suppl.e19002
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e19002
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Nanoparticle Albumin-Bound Paclitaxel and Solvent-Based Paclitaxel as Chemotherapy Options for Patients With Advanced Gastric Cancer: A Systematic Review and Meta-Analysis
    Gangannapalle, Mahesh
    Shahnoor, Husna
    Sattar, Lubna
    Nagi, Talwinder K.
    Al-Tekreeti, Marwah
    Khan, Muhammad Waqas
    Haseeb, Madiha D.
    Khan, Areeba
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (07)
  • [32] Cost-effectiveness analysis of eribulin versus dacarbazine in patients with advanced liposarcoma
    Zhang, Miaomiao
    Huang, Jinlong
    Zheng, Xiaochun
    Huang, Ping
    Yang, Xiuli
    SCIENTIFIC REPORTS, 2025, 15 (01):
  • [33] A phase III trial of nab-paclitaxel versus dacarbazine in chemotherapy-naive patients (pts) with metastatic melanoma: Analysis of peripheral neuropathy.
    Del Vecchio, Michele
    Hersh, Evan
    Brown, Michael Paul
    Clements, Arthur
    Loquai, Carmen
    Ferrucci, Pier Francesco
    Robert, Caroline
    Li, Mingyu
    Elias, Ilena
    Renschler, Markus F.
    Hauschild, Axel
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [34] Enhanced performance of macrophage-encapsulated nanoparticle albumin-bound-paclitaxel in hypo-perfused cancer lesions
    Leonard, Fransisca
    Curtis, Louis T.
    Yesantharao, Pooja
    Tanei, Tomonori
    Alexander, Jenolyn F.
    Wu, Min
    Lowengrub, John
    Liu, Xuewu
    Ferrari, Mauro
    Yokoi, Kenji
    Frieboes, Hermann B.
    Godin, Biana
    NANOSCALE, 2016, 8 (25) : 12544 - 12552
  • [35] A phase I trial of azacitidine and nanoparticle albumin bound paclitaxel in patients with advanced or metastatic solid tumors
    Cohen, Adam L.
    Ray, Abhijit
    Van Brocklin, Matthew
    Burnett, David M.
    Bowen, Randy C.
    Dyess, Donna L.
    Butler, Thomas W.
    Dumlao, Theresa
    Khong, Hung T.
    ONCOTARGET, 2017, 8 (32) : 52413 - 52419
  • [36] Nanoparticle albumin-bound paclitaxel can be useful agent to advanced primary mucinous carcinoma of the skin
    Homma, E.
    Hata, H.
    Tsujiwaki, M.
    Aoyagi, S.
    Shimizu, H.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2015, 29 (11) : 2271 - 2273
  • [37] A randomized, controlled phase III trial of nab-Paclitaxel versus dacarbazine in chemotherapy-naive patients with metastatic melanoma
    Hersh, E. M.
    Del Vecchio, M.
    Brown, M. P.
    Kefford, R.
    Loquai, C.
    Testori, A.
    Bhatia, S.
    Gutzmer, R.
    Conry, R.
    Haydon, A.
    Robert, C.
    Ernst, S.
    Homsi, J.
    Grob, J. J.
    Kendra, K.
    Agarwala, S. S.
    Li, M.
    Clawson, A.
    Brachmann, C.
    Karnoub, M.
    Elias, I.
    Renschler, M. F.
    Hauschild, A.
    ANNALS OF ONCOLOGY, 2015, 26 (11) : 2267 - 2274
  • [38] Sintilimab Combined with Nanoparticle Albumin-Bound Paclitaxel-Based Chemotherapy in Severe Locally Advanced or Metastatic Squamous NSCLC Showed Good Efficacy and Safety: A Pilot Retrospective Analysis
    Zhong, Yonghong
    Mao, Yanxiong
    Fu, Xiaofang
    Huang, Huaqiong
    INTERNATIONAL JOURNAL OF NANOMEDICINE, 2024, 19 : 11433 - 11444
  • [39] Nanoparticle albumin-bound paclitaxel and ramucirumab versus paclitaxel and ramucirumab as second-line chemotherapy for unresectable advanced or recurrent gastric cancer: a multicenter, propensity score-matched analysis (CROSS SELL study)
    Akio Nakasya
    Yuya Hagiwara
    Tatsuki Ikoma
    Yusuke Kurioka
    Toshihiko Matsumoto
    Yoshiyuki Yamamoto
    Takao Tsuduki
    Takeshi Kajiwara
    Toshikazu Moriwaki
    Tomohiro Nishina
    Natsumi Yamashita
    Ichinosuke Hyodo
    International Journal of Clinical Oncology, 2022, 27 : 684 - 694
  • [40] Nanoparticle albumin-bound paclitaxel and ramucirumab versus paclitaxel and ramucirumab as second-line chemotherapy for unresectable advanced or recurrent gastric cancer: a multicenter, propensity score-matched analysis (CROSS SELL study)
    Nakasya, Akio
    Hagiwara, Yuya
    Ikoma, Tatsuki
    Kurioka, Yusuke
    Matsumoto, Toshihiko
    Yamamoto, Yoshiyuki
    Tsuduki, Takao
    Kajiwara, Takeshi
    Moriwaki, Toshikazu
    Nishina, Tomohiro
    Yamashita, Natsumi
    Hyodo, Ichinosuke
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2022, 27 (04) : 684 - 694
12345